$17.25 - SMMT | Summit Therapeutics Inc. Common Stock

Summit Therapeutics Inc. Common Stock (SMMT)

Summit Therapeutics Inc. Common Stock

XNAS:SMMT

17.25

-0.12%

Ask

$19.66 - 150.00

Bid

$17.04 - 270.00

Low

$17.03

High

$17.48

Open

$17.26

Prev Close

$17.27

52W High

36.91

52W Low

15.55

Volume

2027218

Avg Vol (3m)

3395823.2

Float

102977311.3

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 03/05/2015

Primary Exchange: XNAS

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Phone: 305-203-2034

Address: 601 Brickell Key Drive

Address 2: Suite 1000

City: Miami

State: FL

Postal Code: 33131

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

159

P/E (TTM)

-13.720000

P/B (TTM)

65.980000

Round Lot

100

Composit FIGI

BBG00X3GQL76

Share Class FIGI

BBG00X3GQL94

Share Class Shares Outstanding

742.85M

Weighted Shares Outstanding

744.44M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion